Aurora Cannabis (ACB) to Release Earnings on Wednesday

Aurora Cannabis (NASDAQ:ACB - Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Wednesday, February 5th. Analysts expect the company to announce earnings of ($0.09) per share and revenue of $80.01 million for the quarter. Investors interested in registering for the company's conference call can do so using this link.

Aurora Cannabis Stock Performance

NASDAQ ACB traded down $0.17 during trading hours on Friday, hitting $3.65. 610,470 shares of the company's stock traded hands, compared to its average volume of 645,899. Aurora Cannabis has a 52 week low of $2.84 and a 52 week high of $9.35. The firm has a market capitalization of $200.24 million, a P/E ratio of -4.80 and a beta of 1.86. The company has a current ratio of 3.83, a quick ratio of 1.88 and a debt-to-equity ratio of 0.07. The business's fifty day moving average price is $4.23 and its two-hundred day moving average price is $5.19.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on ACB shares. TD Securities raised shares of Aurora Cannabis to a "strong-buy" rating in a research report on Thursday, December 12th. TD Cowen started coverage on Aurora Cannabis in a report on Wednesday, December 11th. They set a "buy" rating for the company.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.